Enzo Biochem Inc ENZ:NYSE

Last Price$2.69NYSE Previous Close - Last Trade as of 7:00PM ET 8/11/22

Today's Change+0.09(3.46%)
Bid (Size)N/A (N/A)
Ask (Size)$3.70 (2)
Day Low / High$2.65 - 2.75
Volume97.3 K

View Biotechnology IndustryPeer Comparison as of 08/11/2022


Enzo Biochem Inc ( NYSE )

Price: $2.69
Change: +0.09 (3.46%)
Volume: 97.3 K
7:00PM ET 8/11/2022

Champions Oncology Inc ( NASDAQ )

Price: $9.40
Change: +0.09 (0.97%)
Volume: 9.6 K
4:00PM ET 8/11/2022

Axcella Health Inc ( NASDAQ )

Price: $2.34
Change: -0.01 (0.43%)
Volume: 15.6 K
4:00PM ET 8/11/2022

CorMedix Inc ( NASDAQ )

Price: $3.72
Change: +0.34 (10.06%)
Volume: 6.00
4:00PM ET 8/11/2022

Galectin Therapeutics Inc ( NASDAQ )

Price: $2.03
Change: +0.02 (1.25%)
Volume: 47.8 K
4:00PM ET 8/11/2022

Read more news Recent News

Enzo Biochem Says Its Laboratory to Begin Accepting Specimens for Monkeypox Tests; Shares Rise
11:35AM ET 8/11/2022 MT Newswires

Enzo Biochem (ENZ) said Thursday its clinical laboratory will start accepting specimens for monkeypox testing this week. The company said the monkeypox...

Insider Buy: Enzo Biochem
4:40PM ET 7/06/2022 MT Newswires

Bradley Louis Radoff, Director, on July 05, 2022, executed a purchase for 120,000 shares in Enzo Biochem (ENZ) for $264,000. Following the Form 4 filing...

Enzo Biochem Wins New York State Approval of HPV Molecular Diagnostic Test
9:49AM ET 4/19/2022 MT Newswires

Enzo Biochem (ENZ) said Tuesday that the New York State Department of Health has approved its Ampiprobe HPV test, a PCR-based test to detect 14 high-risk...

Enzo Biochem Appoints Kara Cannon as Chief Operating Officer
5:03PM ET 3/28/2022 MT Newswires

Enzo Biochem (ENZ) said Monday it appointed Kara Cannon as chief operating officer from her previous role as chief commercial officer. Meanwhile, Chief...

Company Profile

Business DescriptionEnzo Biochem, Inc. is an integrated diagnostics, clinical lab, and life sciences company, which focuses on delivering and applying advanced technology capabilities to produce affordable reliable products and services that enable customers to meet their clinical needs. It operates through the following segments: Products, Clinical Services, and Therapeutics. The Products segment develops, manufactures, and markets products to research and pharmaceutical customers. The Clinical Services segment provides diagnostic services to the health care community. The Therapeutics segment conducts research and development activities for therapeutic drug candidates. The company was founded by Elazar Rabbani, Barry W. Weiner and Shahram K. Rabbani in 1976 and is headquartered in New York, NY. View company web site for more details
Address527 Madison Avenue
New York, New York 10022
Number of Employees503
Recent SEC Filing07/19/20224
Chief Executive Officer & DirectorHamid Erfanian
Chief Operating OfficerKara Cannon
CFO, Secretary, Treasurer & Senior Vice PresidentDavid A. Bench
Chief Medical Director & VP-Medical AffairsDieter Schapfel

Company Highlights

Price Open$2.72
Previous Close$2.69
52 Week Range$1.98 - 4.15
Market Capitalization$131.1 M
Shares Outstanding48.7 M
SectorHealth Technology
Next Earnings Announcement10/11/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.05
Beta vs. S&P 500N/A
Revenue$104.7 M
Net Profit Margin-5.88%
Return on Equity-9.99%

Analyst Ratings as of 07/01/2016

Consensus RecommendationConsensus Icon
Powered by Factset